We build clinicaltrial software in Africafor the world.
The only African clinical trial software dual-compliant with the US FDA and EU Annex 11. Founded in Pretoria in 2015. Deployed across 65+ countries on five continents.
Africa carries roughly a quarter of the global disease burden.
It hosts less than 3% of clinical trials.
Paper-based processes, fragmented data and expensive international software were the obstacles. In 2015, Adriaan Kruger, Abraham van Wyk and Charl Bachuis founded nuvoteQ in Pretoria to remove these obstacles — purpose-built electronic research records for the African context, engineered to meet the world's strictest regulatory frameworks from day one.
A decade on, the platforms are deployed across five continents. The mission hasn't changed: world-class software, built in Africa, accessible everywhere.
“Our goal is to offer our customers world-class software built in Africa for Africa, at an affordable price.”
Cost-effective.
Affordable, enterprise-grade software that competes directly with global platforms on capability, not on price.
Flexible & adaptable.
A configurable front-end over a cohesive, interoperable back-end. Every deployment fits the customer's protocol via our no-code front-end interface.
Accessible to all.
Engineered for resource-constrained research environments and decentralised, multi-site African trials.
Configurable front-end.
Cohesive, interoperable back-end.
We specialise in Electronic Research Records (ERR) for clinical research — eliminating the paper, transcription and fragmentation that slow down trials. Every customer's protocol fits via a no-code front-end interface, not consulting hours.
From brief to go-live.
Identify.
Discovery — protocol, sites, sponsors, regulators.
Configure.
Customised stack via our no-code front-end interface.
Deploy.
Launch with full regulatory cover.
Support.
Continuous SLA-backed partnership.
Efficiency meets precision.
Five cross-functional specialists between Pretoria, Cape Town and the regional hubs — running technology, product, operations, customer success and digital from one accountable team.
Five hubs.
One company.
Hazelwood Incub8tor, 47 Hazelwood Rd, Pretoria, 0081, South Africa — plus regional hubs across Africa, Asia, Europe and Latin America.
- HQ
Pretoria
South Africa
Cape Town
South Africa
Nairobi
Kenya
Bangalore
India
Belo Horizonte
Brazil
- Soon
Cyprus
Coming 2026
Three organisations.
One value chain.
Together, the three form Nuvogenix — one group spanning clinical-trial tech, data science and public health. Sponsors, CROs and research institutions engage with a single integrated stack, contracted, supported and delivered as one accountable partnership across the full trial lifecycle.
- nuvoteQCore
Clinical Trial Tech
Kronus (CTMS), Nukleus (EDC) and SafetyBase (PV) — the regulator-ready platform backbone.
- Scigenix.ai
AI · Data Science
Biostatistics, CDM, medical writing and AI tooling (LEXI, Checkm8, Project J) integrated directly with nuvoteQ data structures.
- nuvoteQ Foundation
Non-profit · Public health
Gates- and EDCTP-funded programmes with SAHPRA and African NRAs — regulatory modernisation and capacity building.
nuvoteQ secures 3rd place
out of 32,000 African Startups.
Africa's Business Heroes · Jack Ma Foundation
nuvoteQ placed third across the continent in the 2025 Africa's Business Heroes competition — recognition of its contribution to clinical research infrastructure across Africa.
Read the full story- Merck
- Pfizer
- Novartis
- GSK
- Gilead
- J&J
- Takeda
- Aspen
- Gates Foundation
- EDCTP
- Science for Africa
- CEPI
- KfW
- GIZ
- SAHPRA
- BOMRA
- NAFDAC
- Rwanda FDA
- AVAREF
- WHO-Afro
Disruptive Innovation. Simplified.